EGFR and lung adenocarcinoma: Recently, whole-genome sequencing analysis and immunohistochemical analysis for elucidation of the evolution of resistance were performed in specimens of advanced lung adenocarcinoma (LADC) with EGFR mutations, which subsequently transformed into SCLC after EGFR TKI treatment [130].